Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 13/20 | 0.68 |
| ▸ | P2RY6 | Q15077 | 5/20 | 0.61 |
| ▸ | P2RY4 | P51582 | 3/20 | 0.61 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.59 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.59 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.59 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.59 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.59 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.59 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.58 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16805401 | 1.00 | P2RY2 (0.68) | P2RY2P2RY6P2RY4ENPP1P2RY1 | |
| SCHEMBL667969 | 1.00 | P2RY2 (0.68) | P2RY2P2RY6P2RY4ENPP1P2RY1 | |
| SCHEMBL18609299 | 1.00 | P2RY2 (0.68) | P2RY2P2RY6P2RY4ENPP1P2RY1 | |
| SCHEMBL17210998 | 1.00 | P2RY2 (0.68) | P2RY2P2RY6P2RY4ENPP1P2RY1 | |
| SCHEMBL14661260 | 0.98 | P2RY2 (0.65) | P2RY2P2RY6P2RY4ENPP1P2RY1 | |
| SCHEMBL14661258 | 0.98 | P2RY2 (0.65) | P2RY2P2RY6P2RY4ENPP1P2RY1 | |
| SCHEMBL16805307 | 0.92 | P2RY2 (0.57) | P2RY2P2RY6P2RY4ENPP1P2RY1 | |
| SCHEMBL903054 | 0.90 | FBP1 (0.57) | P2RY2P2RY6P2RY4P2RY1P2RY11 | |
| SCHEMBL17809090 | 0.90 | FBP1 (0.57) | P2RY2P2RY6P2RY4P2RY1P2RY11 | |
| SCHEMBL3504116 | 0.90 | FBP1 (0.57) | P2RY2P2RY6P2RY4P2RY1P2RY11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3035 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060818-A | Chemically modified circular RNA molecules, methods of making and uses thereof | 上海元码智药生物技术有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-12600957-B2 | Synthesis of transcripts using VSW-3 RNA polymerase | RNASYN BIOTECH. CO., LTD. (CN) | 2026-04-14 | — | — | US | claimed |
| EP-4689071-A2 | MRNA THERAPEUTICS FOR OOCYTE MATURATION | Eastern Virginia Medical School (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4673553-A2 | METHODS AND DEVICES FOR PREPARING CAPPED RNA BY FED-BATCH TRANSCRIPTION | Ribopro B.V. (NL) | 2026-01-07 | — | — | EP | claimed |
| US-12460204-B2 | Artificial nucleic acid molecules for improved protein or peptide expression | CureVac SE (DE) | 2025-11-04 | — | — | US | claimed |
| US-20250270558-A1 | CIRCRNAS FOR GENE SILENCING | MAX PLANCK GESELLSCHAFT (DE) | 2025-08-28 | — | — | US | claimed |
| CN-120189502-A | Mycobacterium tuberculosis antigen combination, mRNA encoding the same and vaccine | 复旦大学 | 2025-06-24 | — | — | CN | claimed |
| US-20250161488-A1 | THERAPEUTIC mRNA | THE UNIVERSITY OF MELBOURNE (AU) | 2025-05-22 | — | — | US | claimed |
| WO-2025096982-A1 | TRANS AMPLIFYING RNAS COMPRISING CHEMICALLY MODIFIED NUCLEOBASES | AMPLITUDE THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| US-20250136711-A1 | SEMENOGELIN NEUTRALIZING ANTIBODY AND EPITOPE AND APPLICATION THEREOF | SHANGHAI BIOTROY BIOTECHNIQUE CO., LTD (CN) | 2025-05-01 | — | — | US | claimed |
| US-20130195867-A1 | RNA-CODED ANTIBODY | CUREVAC GMBH (DE) | 2013-08-01 | — | — | US | claimed |
| EP-2235177-B1 | METHOD FOR ENZYMATIC SYNTHESIS OF CHEMICALLY MODIFIED RNA | RIBOXX GMBH (DE) | 2012-07-18 | — | — | EP | claimed |
| US-20100189729-A1 | RNA-CODED ANTIBODY | CURVAC GMBH (DE) | 2010-07-29 | — | — | US | claimed |
| US-20100047261-A1 | BASE-MODIFIED RNA FOR INCREASING THE EXPRESSION OF A PROTEIN | CUREVAC GMBH (DE) | 2010-02-25 | — | — | US | claimed |
| EP-2101823-A2 | RNA-CODED ANTIBODY | Curevac GmbH (DE) | 2009-09-23 | — | — | EP | claimed |
| EP-2083851-A2 | (BASE-)MODIFIED RNA FOR INCREASING THE EXPRESSION OF A PROTEIN | Curevac GmbH (DE) | 2009-08-05 | — | — | EP | claimed |
| WO-2008083949-A2 | RNA-CODED ANTIBODY | CUREVAC GMBH (DE) | 2008-07-17 | — | — | WO | claimed |
| WO-2008052770-A2 | (BASE-)MODIFIED RNA FOR INCREASING THE EXPRESSION OF A PROTEIN | CUREVAC GMBH (DE) | 2008-05-08 | — | — | WO | claimed |
| EP-1848827-A2 | METHODS AND COMPOSITIONS FOR TAGGING AND IDENTIFYING POLYNUCLEOTIDES | Compass Genetics, Llc (US) | 2007-10-31 | — | — | EP | claimed |
| WO-2006086210-A2 | METHODS AND COMPOSITIONS FOR TAGGING AND IDENTIFYING POLYNUCLEOTIDES | COMPASS GENETICS, LLC (US) | 2006-08-17 | — | — | WO | claimed |